Hematology
Showing 9976 - 10000 of >10,000
Pancreatic Cancer Trial in Canada, United States (gemcitabine HCl, tacedinaline)
Completed
- Pancreatic Cancer
- gemcitabine hydrochloride
- tacedinaline
-
Los Angeles, California
- +15 more
Aug 8, 2012
Conventional and Experimental Chemotherapy With Allogeneic
Unknown status
- Acute Myeloid Leukemia
-
Torino, ItalyCittà della Salute e della Scienza di Torino
Feb 6, 2013
MDS Trial in Worldwide (infliximab)
Completed
- Myelodysplastic Syndromes
- infliximab
-
Brugge, Belgium
- +18 more
Jul 13, 2012
Breast Cancer, Endometrial Cancer Trial in United States (medroxyprogesterone, tamoxifen citrate, adjuvant therapy)
Completed
- Breast Cancer
- Endometrial Cancer
- medroxyprogesterone
- +2 more
-
Mobile, Alabama
- +121 more
Oct 30, 2012
Epidermal Growth Factor Receptor Inhibitors on Magnesium
Terminated
- Solid Tumor
- laboratory biomarker analysis
- (no location specified)
Jan 28, 2013
Motavizumab Administration for a Second Season for RSV Prophylaxis Trial in Porto Alegre, Ribeirao Preto, Santiago (motavizumab
Completed
- Motavizumab Administration for a Second Season for RSV Prophylaxis
- motavizumab (MEDI-524)
- palivizumab 15 mg/kg
-
Porto Alegre, Brazil
- +5 more
Apr 3, 2013
Infection, Human Immunodeficiency Virus Trial (Dolutegravir 50 mg, Calcium Carbonate 1200 mg, Ferrous Fumarate 324 mg)
Completed
- Infection, Human Immunodeficiency Virus
- Dolutegravir 50 mg
- +2 more
- (no location specified)
Apr 18, 2013
Lung Cancer Trial in Canada, United States (gemcitabine HCl, tacedinaline)
Completed
- Lung Cancer
- gemcitabine hydrochloride
- tacedinaline
-
Los Angeles, California
- +15 more
Aug 8, 2012
Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage IVA Adult Soft Tissue Sarcoma Trial in Canada,
Withdrawn
- Stage III Adult Soft Tissue Sarcoma
- +4 more
- doxorubicin
- +11 more
-
Birmingham, Alabama
- +234 more
Jun 25, 2013
D-Dimer, Fibrinogen and PAI-1 in Elderly Infection and
Completed
- Infection
- +2 more
- (no location specified)
Jan 15, 2013
Hormone-Refractory Prostate Cancer, Prostatic Tumors Trial in Worldwide (YM598)
Terminated
- Hormone-Refractory Prostate Cancer
- Prostatic Neoplasms
-
Anchorage, Alaska
- +52 more
Jun 6, 2012
Sarcoma Trial in Canada, United States (biological, drug, procedure, radiation)
Completed
- Sarcoma
- filgrastim
- +6 more
-
Birmingham, Alabama
- +225 more
Jun 20, 2013
Type I Gaucher Disease Trial in Monmouth Junction (Ambroxol)
Suspended
- Type I Gaucher Disease
-
Monmouth Junction, New JerseyExSAR Corporation
Feb 12, 2013
Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer Trial in United States (atrasentan HCl, doxil)
Terminated
- Fallopian Tube Cancer
- +2 more
- atrasentan hydrochloride
- doxil
-
Macon, Georgia
- +5 more
May 16, 2012
Type II Diabetes Trial in United States (JTT-654, JTT-654 Placebo)
Terminated
- Type II Diabetes Mellitus
- JTT-654
- JTT-654 Placebo
-
Birmingham, Alabama
- +41 more
Jan 31, 2013
Lymphoma Trial in Chicago, Rochester (biological, drug, procedure, radiation)
Completed
- Lymphoma
- filgrastim
- +7 more
-
Chicago, Illinois
- +2 more
May 31, 2012
Magnetic Resonance Imaging of Tumor Response and Cognitive
Withdrawn
- Breast Cancer
-
Dayton, Ohio
- +1 more
Apr 4, 2012
COPD Trial in Worldwide (QVA149, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- QVA149
- Placebo
-
Toronto, Ontario, Canada
- +52 more
Jan 28, 2013